TransMedics Group Faces Class Action Lawsuit Over Alleged Securities Fraud

TransMedics Group, Inc. is facing a class action securities lawsuit filed on behalf of investors who purchased shares between February 28, 2023, and January 10, 2025, due to allegations of securities fraud. The lawsuit accuses the company of using kickbacks, fraudulent overbilling, and coercive practices, as well as concealing safety issues related to its Organ Care System. Investors became aware of these allegations following a letter from U.S. Rep. Paul Gosar in February 2024 and a critical report from Scorpion Capital in January 2025, which triggered significant stock price declines. Despite reporting strong quarterly earnings, investor confidence has been shaken by these allegations, leading to ongoing legal scrutiny and an invitation for affected shareholders to join the lawsuit before the April 15, 2025 deadline. Multiple law firms are actively seeking lead plaintiffs to represent the class in this case. The situation underscores the tension between the company's reported financial successes and the serious legal challenges it faces.